The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Meanwhile, the group taking Zepbound (sold as Mounjaro for weight loss in some markets ... for people living with ...

“It slows down gastric emptying, reduces appetite, decreases food intake, so you lose weight,” Azar said. Trizepatide (Zepbound), on the other hand, mimics two different hormones — GLP-1 ...